73.87
+0.69(+0.94%)
Currency In USD
| Previous Close | 73.18 |
| Open | 73.18 |
| Day High | 74.54 |
| Day Low | 72.59 |
| 52-Week High | 111.29 |
| 52-Week Low | 47.25 |
| Volume | 640,771 |
| Average Volume | 950,401 |
| Market Cap | 5.02B |
| PE | 30.65 |
| EPS | 2.41 |
| Moving Average 50 Days | 66.06 |
| Moving Average 200 Days | 65.92 |
| Change | 0.69 |
If you invested $1000 in Lantheus Holdings, Inc. (LNTH) 10 years ago, it would be worth $36,210.78 as of February 21, 2026 at a share price of $73.87. Whereas If you bought $1000 worth of Lantheus Holdings, Inc. (LNTH) shares 5 years ago, it would be worth $3,827.46 as of February 21, 2026 at a share price of $73.87.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
GlobeNewswire Inc.
Feb 12, 2026 1:00 PM GMT
BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 26, 2026, to discuss its financial and op
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
GlobeNewswire Inc.
Jan 02, 2026 1:00 PM GMT
BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver bette
Lantheus to Present Florbetaben F 18 Data at CTAD 2025
GlobeNewswire Inc.
Nov 24, 2025 1:30 PM GMT
BEDFORD, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient out